Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
QuintilesIMS
Novartis
Argus Health
Merck
Boehringer Ingelheim
Julphar
Teva
Cantor Fitzgerald
Johnson and Johnson

Generated: October 18, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 073262

« Back to Dashboard
NDA 073262 describes SULINDAC, which is a drug marketed by Epic Pharma, Sandoz, Mylan, Sun Pharm Inds, Epic Pharma Llc, Ani Pharms Inc, and Watson Labs, and is included in twelve NDAs. It is available from twenty-two suppliers. Additional details are available on the SULINDAC profile page.

The generic ingredient in SULINDAC is sulindac. There are fourteen drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the sulindac profile page.

Summary for NDA: 073262

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Analgesics
Anti-inflammatory Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 073262

Suppliers and Packaging for NDA: 073262

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SULINDAC
sulindac
TABLET;ORAL 073262 ANDA Heritage Pharmaceuticals Inc. 23155-005 23155-005-01 100 TABLET in 1 BOTTLE (23155-005-01)
SULINDAC
sulindac
TABLET;ORAL 073262 ANDA Heritage Pharmaceuticals Inc. 23155-005 23155-005-05 500 TABLET in 1 BOTTLE (23155-005-05)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength200MG
Approval Date:Sep 6, 1991TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength150MG
Approval Date:Sep 6, 1991TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Healthtrust
Daiichi Sankyo
Medtronic
Teva
Novartis
Boehringer Ingelheim
Cantor Fitzgerald
Chinese Patent Office
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot